Showing posts with label stem cell. Show all posts
Showing posts with label stem cell. Show all posts

Sunday, September 8, 2013

Diabetes - By Dr. Dipnarine Maharaj MD

Diabetes

THE ROOT CAUSE OF DIABETES IS INFLAMMATION. 

What is Diabetes?
Diabetes is the condition in which the body does not properly process food for use as energy. Most of the food we eat is turned into glucose, or sugar, for our bodies to use for energy. The pancreas, an organ that lies near the stomach, makes a hormone called insulin to help glucose get into the cells of our bodies. When you have diabetes, your body either doesn’t make enough insulin or can’t use its own insulin as well as it should. This causes sugars to build up in your blood. This is why many people refer to diabetes as “sugar.” Diabetes can cause serious health complications including heart disease, blindness, kidney failure, and lower-extremity amputations. Diabetes is the seventh leading cause of death in the United States.
Diabetes is the seventh leading cause of death in the United States. Characterized by unusually high levels of sugar glucose in the bloodstream, it is responsible for much of the complications of the disease, including liver disease and stroke.
How can Stem Cells help treat Diabetes?
Today, new treatments and advances in research are giving new hope to people affected by diabetes. Adult stem cells have been shown to be precursors to embryonic and islet stem cells that produce insulin.  However any and all stem cell treatments are considered experimental and should only be done under the supervision of a licensed and trained specialist.  With more research and treatment, soon new breakthroughs will help patients with diabetes.


Tuesday, August 6, 2013

Walking, cycling to work may curb diabetes risk - Recommended by Dr. Dipnarine Maharaj M.D. FACP

Walking, cycling to work may curb diabetes risk  - Recommended by Dr. Dipnarine Maharaj M.D. FACP


http://www.cbsnews.com/8301-204_162-57597236/walking-cycling-to-work-may-curb-diabetes-risk/


By
Michelle Castillo /
CBS News/ August 6, 2013, 2:55 PM

Walking, cycling to work may curb diabetes risk


 
Do you walk to work? Your daily jaunt may be cutting your risk of developing Type 2 diabetes by about 40 percent.
A new study published in the American Journal of Preventative Medicine on Aug. 6 looked at the various methods people use to get to work and how it impacted their health. Not surprisingly, driving was not the top way to protect against obesity and chronic disease.
Researchers surveyed 20,000 people across the U.K. for the study. They found that people who cycled, walked and used public transportation were less likely to be overweight than those who drove.
About 19 percent of responders who used a private mode of transportation for their work travel -- including cars, motorbikes or taxis -- were obese. Only 15 percent of walkers and 13 percent of cyclists, however, were obese.
The researchers found other health benefits. Cyclists were about 50 percent less likely to have diabetes compared to drivers. People who walked to work were 40 percent less likely to have diabetes and 17 percent less likely to have high blood pressure compared to those who took their cars.
"This study highlights that building physical activity into the daily routine by walking, cycling or using public transport to get to work is good for personal health ," study co-author Anthony Laverty, a research assistant at the School of Public Health at Imperial College London, said in a press release.
About 25.8 million children and adults in the U.S. have diabetes, the American Diabetes Association reports. Type 2 diabetes, the most common form of the disease, is a condition in which the body cannot correctly use a hormone called insulin, which helps regulate the amount of sugar in blood.
One out of three American adults has high blood pressure or hypertension, according to the Centers for Disease Control and Prevention.
Obesity is a risk factor for both of those diseases. The CDC reports that more than one-third of U.S. adults are obese.
Dr. Chris Millett, a medical faculty member at the School of Public Health at the Imperial College London who co-authored the study, added to diabetes.co.uk that it is known that walking is better than staying seated on the way to work. But, even he was surprised at how much physical activity helped lower rates of diabetes and high blood pressure.
Recent research also shows that walking offers protective health benefits. Short 15-minute walks after meals have been shown to lower the risk of Type 2 diabetes. An April 2013 study showed that walking may be just as good as running when it comes to heart benefits.
Alas, the CDC reports that 80 percent of U.S. adults don't get the recommended weekly amount of physical activity. The agency advises at least 2.5 hours of moderate-intensity aerobic exercise each week, one hour and 15 minutes of vigorous-intensity activity or a combination of both. Adults should also engage in muscle-strengthening activities like lifting weights or doing push-ups at least twice per week.
"We are recommended to have at least 30 minutes' moderate exercise a day so only a 15-minute walk at either end and you have done your quota -- although the longer the better," Millett said. "It's also more convenient than going to the gym because it can be factored in as part of your day without having to set aside any other time."
© 2013 CBS Interactive Inc. All Rights Reserved.

http://www.cbsnews.com/8301-204_162-57597236/walking-cycling-to-work-may-curb-diabetes-risk/


Diabetes Clinical Trial - Dr. Dipnarine Maharaj

Diabetes Clinical Trial - Dr. Dipnarine Maharaj

 
 
The Stem Cell Cancer Regenerative Medicine Research Foundation Inc. is seeking funding for research to uncover the inflammatory basis of degenerative diseases such as Diabetes Mellitus and to determine whether treating the inflammation will play a crucial role in altering the underlying biology of this disease which affects 24 million people in the United States and 241 million people worldwide. 

Diabetes Expert Dr. Dipnarine Maharaj M.D. FACP


 
Inflammation is part of the body’s normal healing response to injury. When blood vessels of  organs such as the pancreas suffer injury as a result of the effects of obesity, excessive sugar intake, smoking and abnormal cholesterol, for instance, the immune system as part of the inflammatory response dispatches cells to repair the damage. But in the face of a constant assault by such irritants over decades, possibly abetted by genetics that system can go into overdrive. Instead of protecting the vessels the inflammation becomes chronic and this leads to the body’s  decreased ability to  metabolize blood sugar and abnormal  insulin production by the pancreas which results in Diabetes. The inflammation of the blood vessels also  lead to the accumulation and potential rupture of arterial deposits called plaque that can cause heart attack and strokes which are common complications of Diabetes.

The goals of the Stem Cell Cancer Regenerative Medicine Research Foundation Inc. Is dedicated to taking actions that will: predict those patients at risk for development of the disease before the actual clinical onset, to prevent the disease; and study the use of stem cells for tissue repair.

The Stem Cell Cancer Regenerative Medicine Research Foundation’s support of the research being conducted by the South Florida Bone Marrow Stem Cell Transplant Institute under the direction of Medical Director, Dipnarine Maharaj, MD, FACP.


Wednesday, July 31, 2013

Dipnarine Maharaj - The Diabetes Clinical Trial Project:

The Diabetes Clinical Trial Project:


Diabetes Expert Dr. Dipnarine Maharaj M.D
Diabetes Expert Dr. Dipnarine Maharaj M.D.
The South Florida Bone Marrow Stem Cell Transplant Institute would like to conduct a Diabetes Clinical Trial under the direction of Medical Director, Dipnarine Maharaj, MD, FACP.  The Diabetes Clinical Trial will involve the treatment of 60 diabetic patients ( 30 Type 1 & 30 Type  2) through a stem cell mobilization treatment.  Patient participants will be required to participate in initial screening processes before acceptance in the clinical trial to ensure that they are healthy enough to undergo the treatment protocol.

The patients selected to participate in the Diabetes Clinical Trial will undergo a series of stem cell mobilization treatments with stem cells for a period of 42 days(6 weeks).  Follow-up visits with the physician as well as all tests and examinations will be included as part of the Clinical Trial so that there is no cost to the patient participant.